| Literature DB >> 19402065 |
Abstract
A variety of prognostic factor models to predict survival in patients with metastatic renal cell carcinoma have been developed. Diverse populations of patients with variable treatments have been used for these analyses. A variety of clinical, pathologic, and molecular factors have been studied, but current models use predominantly easily obtained clinical factors. These approaches are reviewed, and current approaches to further refine and develop these techniques are reviewed. (c) 2009 American Cancer Society.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19402065 DOI: 10.1002/cncr.24226
Source DB: PubMed Journal: Cancer ISSN: 0008-543X Impact factor: 6.860